Eyes wide shut
In the primary visual cortex of the brain, neurons are organized into alternating columns that receive inputs from either the left or right eye. This organization is strongly dependent on early visual experience.
When one eye is deprived of visual inputs during a critical developmental period, the corresponding columns fail to develop properly, whereas those receiving inputs from the unaffected eye grow larger than normal.
The cortex consists primarily of two different types of neuron: excitatory neurons that synthesize and release the neurotransmitter glutamate, and inhibitory interneurons which use the transmitter ã-aminobutyric acid (GABA). How each of these cell types contributes to experience-dependent changes in the visual cortex is, however, unknown.
To investigate this, Tadaharu Tsumoto of the RIKEN Brain Science Institute, Wako, and his colleagues injected a calcium-sensitive dye, Fura-2, into the visual cortex of genetically engineered mice whose inhibitory interneurons express a fluorescent protein called Venus1. The intensity of Fura-2 fluorescence changes in response to the increase in calcium ion concentration that is characteristic of neuronal activity.
This approach enabled the researchers to both identify the interneurons in the visual cortex and monitor their activity. In animals reared normally, they first identified the ‘binocular’ regions of the primary visual cortex by visually stimulating each eye in turn, and using two-photon laser-scanning microscopy to locate the cells that responded to both. This revealed that inhibitory interneurons are more responsive to inputs from both eyes than excitatory neurons.
The responses in mice deprived of visual inputs to one eye for two days during the critical period were then examined. The change in the responses of both cell types was found to be similar—both had become more responsive to inputs from the open eye.
When mice were deprived of visual inputs to one eye after the critical period, however, the effect observed was far stronger on the inhibitory interneurons. They tended to receive inputs from the open eye, and their responses to inputs from the closed eye were also depressed, whereas those of the excitatory neurons remained almost stable. The interneurons normally act to inhibit the excitatory neurons, so their depressed responses may contribute to the stability of excitatory neuron responses to the deprived eye.
“Inhibitory interneurons are divided into several subtypes,” says Tsumoto. So, the next step is to determine which particular subtypes are involved in maintaining plasticity after the critical period.
The corresponding author for this highlight is based at the Laboratory for Cortical Circuit Plasticity, RIKEN Brain Science Institute
Journal information
1. Kameyama, K., Sohya, K., Ebina, T., Fukuda, A., Yanagawa, Y. & Tsumoto, T. Difference in binocularity and ocular dominance plasticity between GABAergic and excitatory cortical neurons. Journal of Neuroscience 30, 1551–1559 (2010)
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
How marine worms regenerate lost body parts
The return of cells to a stem cell-like state as the key to regeneration. Many living organisms are able to regenerate damaged or lost tissue, but why some are particularly…
Nano-scale molecular detective
New on-chip device uses exotic light rays in 2D material to detect molecules. Researchers have developed a highly sensitive detector for identifying molecules via their infrared vibrational “fingerprint”. Published in Nature…
Novel CAR T-cell therapy
… demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors. The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors….